We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$9.95B
Cap. Flow %
3.83%
Top 10 Hldgs %
14.4%
Holding
8,581
New
810
Increased
3,919
Reduced
2,793
Closed
626

Sector Composition

Rank Sector Weight
1 Technology 9.74%
2 Financials 7.41%
3 Healthcare 6.49%
4 Consumer Discretionary 5.87%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNTR
6551
DELISTED
Pointer Telocation Ltd.
PNTR
$22K ﹤0.01%
1,433
+324
+29% +$4.85K
AMR
6552
DELISTED
Alta Mesa Resources Inc
AMR
$22K ﹤0.01%
150,095
+116,159
+342% +$22K
NYNY
6553
DELISTED
Empire Resorts, Inc.
NYNY
$22K ﹤0.01%
2,222
+1,200
+117% +$14.1K
TYNS
6554
DELISTED
Direxion Daily 7-10 Year Treasury Bear 1X Shares
TYNS
$22K ﹤0.01%
837
+54
+7% +$1.48K
LJPC
6555
DELISTED
La Jolla Pharmaceutical Company
LJPC
$22K ﹤0.01%
2,295
-1,074
-32% -$8.09K
ACIU icon
6556
AC Immune
ACIU
$226M
$21K ﹤0.01%
3,765
-343
-8% -$1.75K
AKRO
6557
DELISTED
Akero Therapeutics
AKRO
$21K ﹤0.01%
+1,118
New +$21.2K
BW icon
6558
Babcock & Wilcox
BW
$1.42B
$21K ﹤0.01%
6,222
+3,558
+134% +$13.7K
IOR
6559
Income Opportunity Realty Investors
IOR
$21K ﹤0.01%
1,634
PVL
6560
Permianville Royalty Trust
PVL
$56.8M
$21K ﹤0.01%
7,790
+7,754
+21,539% +$23.7K
REAL icon
6561
The RealReal
REAL
$1.51B
$21K ﹤0.01%
+732
New +$21.2K
REK icon
6562
ProShares Short Real Estate
REK
$11.7M
$21K ﹤0.01%
763
-497
-39% -$14K
XBIO icon
6563
Xenetic Biosciences
XBIO
$6.09M
$21K ﹤0.01%
185
+173
+1,442% +$22.9K
TBCH
6564
Turtle Beach Corp
TBCH
$254M
$21K ﹤0.01%
1,779
-13,262
-88% -$140K
OSG
6565
DELISTED
Overseas Shipholding Group Inc.
OSG
$21K ﹤0.01%
+11,171
New +$20.7K
ARDS
6566
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$21K ﹤0.01%
2,063
+412
+25% +$3.96K
USX
6567
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$21K ﹤0.01%
4,163
+3,913
+1,565% +$23.9K
SECO
6568
DELISTED
Secoo Holding Limited ADR
SECO
$21K ﹤0.01%
282
+115
+69% +$9.9K
JHCS
6569
DELISTED
John Hancock Multifactor Media and Communications ETF
JHCS
$21K ﹤0.01%
+797
New +$20.8K
AMRB
6570
DELISTED
American River Bankshares
AMRB
$21K ﹤0.01%
+1,712
New +$21.7K
VSLR
6571
DELISTED
VIVINT SOLAR, INC.
VSLR
$21K ﹤0.01%
2,994
+2,197
+276% +$13.9K
PPSC
6572
DELISTED
PortfolioPlus S&P Small Cap ETF
PPSC
$21K ﹤0.01%
589
+280
+91% +$9.89K
SLIM
6573
DELISTED
The Obesity ETF
SLIM
$21K ﹤0.01%
620
-265
-30% -$8.83K
LVOXU
6574
DELISTED
LiveVox Holding, Inc. Unit
LVOXU
$21K ﹤0.01%
2,124
-6,100
-74% -$61.4K
BKSC
6575
DELISTED
Bank of South Carolina
BKSC
$21K ﹤0.01%
1,125
-958
-46% -$17.8K

Similar funds

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $9.95B of net new capital in Q2 2019, opening 810 new positions and adding to 3,919 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 810 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.